Breaking Supreme Court Lifts Block on Trump’s Mail-In Voting Order, Future Challenges Remain California Aids Federal Efforts Amidst Stretched Wildfire Crews Justice Department Warns of Financial Ruin for Kennedy Center Over Trump Name Dispute PGA Tour Announces New Postseason Format for 2026 Republican Stance on Data Centers Shifts Amidst Voter Concerns

Tuesday August 25, 2026

Reporter

LEADS BIOLABS CO., LTD.

4Articles Published

5Communities Covered

Published Articles

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage

9 hours ago

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Aug 20

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Aug 20

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

Aug 20